Yao, 2008 trial summary

A randomised clinical trial investigating the effect of Bone marrow mononuclear cells versus control in patients with stable ischaemic heart disease due to a previous MI

Zhonghua Xin Xue Guan Bing Za Zhi 2006 Jul;34:577-81  




Studied treatment intracoronary bone marrow mononuclear cells
Control treatment



Patients patients with stable ischaemic heart disease due to a previous MI
Group sizes 24 / 23



Blindness Inclusion period
Follow-up duration Centers
Lost to FU geographical localisation
Primary endpoint Design



EndpointX1N1X0N0TE95% CI LV End-Systolic Volume - -9 - -9 no data ventricular tachycardia - -9 - -9 no data NT-proBNP - -9 - -9 no data NYHA deterioration - -9 - -9 no data Peak VO2 (mL/kg/min) - -9 - -9 no data NYHA class - -9 - -9 no data cardiac event - 24 - 23 no data Minnesota Living With Heart Failure Questionnaire - -9 - -9 no data 6-min Walk, m - -9 - -9 no data all-cause mortality - -9 - -9 no data LVEF - -9 - -9 no data acute heart failure - -9 - -9 no data0,22,01,0


Yao K, Huang R, Qian J, Cui J, Ge L, Li Y, Zhang F, Shi H, Huang D, Zhang S, Sun A, Zou Y, Ge J Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function. Heart 2008;94:1147-53     [PMID: 18381377]   link to pdf  

Yao K, Huang RC, Ge L, Qian JY, Li YL, Xu SK, Zhang F, Zhang YQ, Niu YH, Shi JH, Zhang SH, Fan B, Wang QB, Sun AJ, Zou YZ, Ge JB [Observation on the safety: clinical trail on intracoronary autologous bone marrow mononuclear cells transplantation for acute myocardial infarction]. Zhonghua Xin Xue Guan Bing Za Zhi 2006 Jul;34:577-81     [PMID: 17081355]   link to pdf  



Registering number (see trial on clinicaltrials.gov)
Code Name

 




Appears in following systematic reviews: